By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


American Association for Cancer Research 

615 Chestnut St.
17th Floor
Philadelphia  Pennsylvania  19106-3483  U.S.A.
Phone: 215-440-9300 Fax: 215-440-9313


Company News
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Data Correlating Immune Response With Reduction Of Relapse In AE37 Phase II Breast Cancer Trial At AACR 2015 4/21/2015 11:41:32 AM
Ariad (ARIA) Announces Results Of Preclinical Studies On Brigatinib At The AACR Annual Meeting 4/21/2015 11:27:41 AM
ArQule, Inc. (ARQL) Announces Data Presentations With ARQ 087, Inhibitor Of FGFR, At AACR 4/21/2015 11:22:44 AM
Guardant Health Results Of Decision Impact Study Of Guardant360 In Metastatic Colorectal Cancer To Be Presented At AACR 4/21/2015 10:04:53 AM
Preclinical Data Presented At AACR Demonstrate Synergistic Anti-Tumor Effects Of Peregrine Pharmaceuticals, Inc. (PPHM)'s Phosphatidylserine (PS)-Targeting Antibodies With Immune Checkpoint Inhibitors In Models Of Melanoma And Breast Cancer 4/21/2015 8:04:09 AM
Arno Therapeutics To Present Promising Data From Phase I Trial Of Onapristone At AACR Annual Meeting 2015 4/21/2015 7:46:24 AM
Calithera Biosciences, Inc. (CALA) Highlights Results From Six Preclinical Abstracts At The AACR Annual Meeting 2015 4/21/2015 7:44:32 AM
Mission Therapeutics Ltd Presents At The Annual Meeting Of AACR The Identification Of Novel Inhibitors Of The UCHL1 Oncogene 4/20/2015 2:54:26 PM
Genticel To Present Further Promising Pharmacology In-Vivo Results Of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (Procervix), At AACR Annual Meeting 2015 4/20/2015 2:20:12 PM
Ligand Pharmaceuticals Inc. (LGND) Partner TG Therapeutics, Inc. (MHA) Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting 4/20/2015 1:45:29 PM